Your finance and banking news reporter from Spain
Provided by AGPStay up to date with press releases covering announcements, company news, product launches, and business updates.
Publish your press release
European Council on Refugees and Exiles (ECRE)
|Published on: 12th May 2026|Categories: News| The updated AIDA Country Report on Spain provides a detailed overview on legislative and practice-related developments in asylum procedures, reception conditions, detention of asylum applicants and...
ECB - European Central Bank
11 May 2026 You’ve been in the eye of the storm as ECB Vice-President for the past eight years.
GlobeNewswire, Inc.
Coface posts a good start to the year, recording net profit of €53.6m; annualised RoATE at 11.0% Paris, 12 May 2026 – 5.35 p.m. Turnover: €465m, stable at constant FX and perimeter Insurance revenue was down by -1.3% at constant FX. Client...
MENAFN
World and Middle East business and financial news, Stocks, Currencies, Market Data, Research, Weather and other data.
MENAFN
World and Middle East business and financial news, Stocks, Currencies, Market Data, Research, Weather and other data.
MENAFN
World and Middle East business and financial news, Stocks, Currencies, Market Data, Research, Weather and other data.
MENAFN
World and Middle East business and financial news, Stocks, Currencies, Market Data, Research, Weather and other data.
MENAFN
World and Middle East business and financial news, Stocks, Currencies, Market Data, Research, Weather and other data.
MENAFN
World and Middle East business and financial news, Stocks, Currencies, Market Data, Research, Weather and other data.
MENAFN
World and Middle East business and financial news, Stocks, Currencies, Market Data, Research, Weather and other data.
GlobeNewswire, Inc.
– Completed Phase 1b studies for ABI-5366 and ABI-1179, helicase-primase inhibitors for recurrent genital herpes – – Completed chronic toxicology studies for ABI-6250, an oral small-molecule entry inhibitor candidate for chronic hepatitis delta...
GlobeNewswire, Inc.
NEW YORK, USA, May 12, 2026 (GLOBE NEWSWIRE) -- Zion Market Research has published a new research report titled “Industrial Lubricant Market By Base Oil (Bio-Based Oil, Synthetic Oil, and Mineral Oil), By Product Type (Gear Oil, Hydraulic Fluid,...
GlobeNewswire, Inc.
Detailed results from RISE UP Phase 3 trial of mitapivat in sickle cell disease selected for distinguished Plenary Abstracts Session Company to host investor conference call and webcast during EHA 2026 on Saturday, June 13, at 9:00 a.m. ET (3:00...
GlobeNewswire, Inc.
Net Income was $26 million.
GlobeNewswire, Inc.
The Company delivered record quarterly net gaming revenue of €64.4 million and Adj. EBITDA of €6.0 million Total revenue was €60.3 mm in Q1 2026, while net gaming revenue1 was €64.4 mm, 13% above Q1 2025. Spain revenue and net gaming revenue were...
EIN Presswire
Firgun Ventures Participates in $160M Series C for Quantum Computing Scale-Up LONDON, UNITED KINGDOM, May 7, 2026 /EINPresswire.com/ -- Firgun Ventures, a $250 million Quantum fund, today announced its first European investment: Quantum Motion,...
GlobeNewswire, Inc.
AUSTIN, Texas, May 07, 2026 (GLOBE NEWSWIRE) -- Filana Therapeutics, Inc. (NASDAQ: FLNA, “Filana Therapeutics”, the “Company”), a biotechnology company currently focused on developing therapies for Tuberous Sclerosis Complex (TSC)-related...
GlobeNewswire, Inc.
Seville, ANDALUCIA, May 06, 2026 (GLOBE NEWSWIRE) -- EuroAmerican Financial Advisors (EAFA) is drawing attention to a growing issue affecting Americans who invest through European financial institutions: a lack of critical information needed for...
GlobeNewswire, Inc.
NEW YORK, USA, May 12, 2026 (GLOBE NEWSWIRE) -- Zion Market Research has published a new research report titled “Coffee Beauty Products Market By Product Type (Hair Care Products, Skincare Products, Body Care Products, Color Cosmetics, and...
GlobeNewswire, Inc.
One-Year Cohort 1 Data and Initial Cohort 2 Data from RIDGE™-1 Phase 1b/2 Trial of TN-401 for PKP2-Associated ARVC to be Presented at ASGCT 2026 New Data from Both Cohorts of the MyPEAK™-1 Phase 1b/2 Trial of TN-201 for Adults with...
Sign up for:
The daily local news briefing you can trust. Every day. Subscribe now.
We sent a one-time activation link to: .
Confirm it's you by clicking the email link.
If the email is not in your inbox, check spam or try again.
is already signed up. Check your inbox for updates.